Results 101 to 110 of about 9,066 (175)

Treatment of ophthalmopathy in the course of Graves’ disease

Journal of Education, Health and Sport, 2019
: Introduction: Graves’ disease is an autoimmune disease in which the TSH receptor (TSHR) is an autoantigen. Its stimulation by antibodies inhibiting thyrotropin binding causes increased secretion of free thyroid hormones and consequently symptoms of ...
Magdalena Woźniak, Ewa Tywanek, Grzegorz Rudzki, Joanna Świrska, Agnieszka Zwolak, Robert Jan Łuczyk   +5 more
doaj  

Isolation and initial characterization of microvascular endothelial cells derived from the retoorbital connective tissue of patients with Graves ophthalmopathy [PDF]

, 1994
Bahn, R. S., Heufelder, A. E., Scriba, Peter Christian   +2 more
core   +1 more source

Immunomodulators in Graves' ophthalmopathy: a systematic review. [PDF]

Front Endocrinol (Lausanne)
Yeung A, Siddiqui MS, Mirtorabi N, Ahmed UN, Watts E, Sharma N, Kumari R, Boelaert K, Muzaffar J, Nieto H.   +9 more
europepmc   +1 more source

Correction: Extraocular muscle index as a novel indicator of inflammatory condition in graves' ophthalmopathy patients. [PDF]

Front Endocrinol (Lausanne)
Wu F, Huang J, Wang M, Qian Z, Wang Y, Fang W.   +5 more
europepmc   +1 more source

Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review. [PDF]

Cureus
Bonny M, Wehbe M, Zaydan R, Alsadi M, Hakim L, Abu Alhasan J, Abu Helwa RS.   +6 more
europepmc   +1 more source

New-Onset Graves' Ophthalmopathy After Treatment with Pembrolizumab: A Case Report and a Review of the Literature. [PDF]

Diagnostics (Basel)
Pan M, Zhou X, Wu Y.
europepmc   +1 more source

Thyrotropin and growth promoting immunoglobulin (TGI) of FRTL-5 cells have no growth stimulating activity on human thyroid epithelial cell cultures [PDF]

, 1987
Bay, V., Dwenger, M., Engel, U., Fenzi, G. F., Ingbar, S. H., Mansky, T., Mckenzie, J. M., Pinchera, Aldo, Scriba, Peter Christian, Wenzel, B. E.   +9 more
core  

Clinical value of dual-energy CT parameters combined with morphological features in predicting graves' ophthalmopathy. [PDF]

BMC Med Imaging
Ma Z, Shi T, Li W, Lu X, Yuan L, Zhang Y, Niu Y, Liu D.   +7 more
europepmc   +1 more source

Emerging therapeutic approaches in graves' ophthalmopathy: an update on pharmacological interventions. [PDF]

Front Immunol
Wang L, Chen L.
europepmc   +1 more source

Effect of orbital fat decompression on eyelid contour according to midpupil lid distance in graves' ophthalmopathy. [PDF]

BMC Ophthalmol
Wang YW, Huang WL, Liao SL, Wei YH.
europepmc   +1 more source